INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 442m ago
HOUSE PTR42m ago
SEC 13F42m ago
ROBINHOOD CHAIN42m ago
Corporate insider
RP

Raman Prakash

DirectorCIK 0002018686

EDGAR filingsOpen in network
Disclosed transactions8
Buys / sells0 / 0
Max Insider Score17
Connections2with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
RP
Raman PrakashDirector
BDTXBlack Diamond Therapeutics, Inc.
Grant or award
A$13K
6,801 sh
Sep 18, 2026Sep 21, 2026
traded Sep 18, 2026
+3dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Olema Pharmaceuticals, Inc.Director · Apr 29, 2026
  • Insider ofevidence
    Black Diamond Therapeutics, Inc.Director · Dec 15, 2025
9
RP
Raman PrakashDirector
BDTXBlack Diamond Therapeutics, Inc.
Grant or award
A
—
40.0K sh
Jun 26, 2026
Jun 29, 2026
traded Jun 26, 2026
+3d
SEC FORM 4

Evidence

15
RP
Raman PrakashDirector
OLMAOlema Pharmaceuticals, Inc.
Grant or award
A—
29.5K sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC FORM 4

Evidence

17
RP
Raman PrakashDirector
BDTXBlack Diamond Therapeutics, Inc.
Grant or award
A$13K
7,907 sh
Jun 19, 2026Jun 22, 2026
traded Jun 19, 2026
+3dSEC FORM 4

Evidence

9
RP
Raman PrakashDirector
OLMAOlema Pharmaceuticals, Inc.
Grant or award
A—
24.1K sh
Apr 28, 2026Apr 29, 2026
traded Apr 28, 2026
+1dSEC FORM 4

Evidence

9
RP
Raman PrakashDirector
OLMAOlema Pharmaceuticals, Inc.
Grant or award
A—
2,911 sh
Apr 28, 2026Apr 29, 2026
traded Apr 28, 2026
+1dSEC FORM 4

Evidence

13
RP
Raman PrakashDirector
BDTXBlack Diamond Therapeutics, Inc.
Grant or award
A$13K
6,105 sh
Mar 20, 2026Mar 20, 2026
traded Mar 20, 2026
+0dSEC FORM 4

Evidence

13
RP
Raman PrakashDirector
BDTXBlack Diamond Therapeutics, Inc.
Grant or award
A$13K
4,665 sh
Dec 12, 2025Dec 15, 2025
traded Dec 12, 2025
+3dSEC FORM 4

Evidence